Fingerprint
Dive into the research topics of 'MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit
Sanne Løkkegaard, Daniel Elias, Carla L. Alves, Martin V. Bennetzen, Anne Vibeke Lænkholm, Martin Bak, Morten F. Gjerstorff, Lene E. Johansen, Henriette Vever, Christina Bjerre, Tove Kirkegaard, Bo Nordenskjöld, Tommy Fornander, Olle Stål, Linda S. Lindström, Laura J. Esserman, Anne E. Lykkesfeldt, Jens S. Andersen, Rikke Leth-Larsen, Henrik J. Ditzel*
*Corresponding author for this work
- Department of Biochemistry and Molecular Biology
- KI, OUH, Research unit of Pathology (Odense)
- Department of Molecular Medicine
- KI, BRIDGE - Brain Research - Inter Disciplinary Guided Excellence (Odense)
- Department of Regional Health Research
- KI, OUH, Research unit of Oncology (Odense)
- KI, OUH, AgeCare - Academy of Geriatric Cancer Research (Odense)
Research output: Contribution to journal › Journal article › Research › peer-review
52
Downloads
(Pure)